Professor Sejal Saglani Faculty of Medicine, National Heart & Lung Institute
Professor of Paediatric Respiratory Medicine
Professor Sejal Saglani leads the Paediatric Severe Asthma Group within the section of Inflammation, Repair and Development at Imperial College London. She is consultant in Paediatric Respiratory Medicine at the Royal Brompton Hospital and part of the Paediatric Difficult Asthma Team.
Areas of expertise and research interests
Professor Saglani’s clinical expertise and research interests include:
management of pre-school children with recurrent wheezing
management of school age children with difficult asthma
factors predicting progression of pre-school wheeze to school-age asthma
the identification of novel therapies for pre-school wheeze and childhood severe asthma
mechanisms mediating severe pre-school wheezing and childhood asthma
Professor Saglani has established a translational research programme. It involves an integrated approach using a neonatal murine model, airway samples from children and direct application and clinical translation of her findings in interventional clinical trials.
President, Indian Chest Society, 2023-2024
Member, Board of Directors, Global Initiative for Chronic Obstructive Lung Disease (GOLD)
Member, Scientific Committee, Global Initiative for Asthma (GINA)
Chair, Chronic Respiratory Diseases Section, Global Burden of Disease, India (2015 onwards)
Member, Steering Committee on Air Pollution and Health, Ministry of Health and Family Welfare, GoI
More than 250 published papers in peer reviewed international journals
Ranked No. 1 Respiratory Scientist in India (Stanford University Ranking 2023, previous year) and No. 52 in the world out of 60,472 global respiratory scientists
Dr Sewa Duu Wen obtained his medical degree from the National University of Singapore in 2003. He completed his specialty training in Respiratory and Critical Care Medicine, as well as Intensive Care Medicine in 2012 and 2014 respectively.
Dr Sewa’s areas of interest include advanced respiratory failure, pulmonary hypertension and lung transplantation. In 2013 and 2015, he was twice awarded the Health Manpower Development Programme (HMDP) Award for training in intensive care medicine and lung transplantation at University Health Network, Toronto, Canada, and then at Papworth Hospital, Cambridge, UK for training in chronic thromboembolic pulmonary hypertension. He is part of the multi-disciplinary team member of the pulmonary hypertension service in National Centre and is the medical director for lung transplantation programme in Singapore. He is currently serving as the Head of Department of Respiratory and Critical Care Medicine in Singapore General Hospital.
Dr Kiran Sharma, is the Deputy Head, Department of Intensive Care Medicine and Consultant, Department of Respiratory Medicine at Sengkang General Hospital in Singapore. She is also the Clinical Lead for the Pleural Medicine. She did a short pleural fellowship at the Sir Charles Gairdner Hospital in Perth, Australia. Her special interest includes Pleural Medicine, Rapid Response Team, Code Blue Resuscitation and Pulmonary Embolism. She is actively involved in teaching of undergraduates, postgraduates and advanced critical care nursing.
Michael J. Simoff has practiced Interventional Pulmonology for 29 years and has been involved in technology development including: EBUS-TBNA, ENB, confocal microendoscopy, OCT, autofluorescence bronchoscopy, and APC as examples. He is a Professor of Medicine, FTA at Wayne State School of Medicine. He has published more than 180 peer-reviewed works, given more than 230 international and national talks, and has been funded more than $18million for research. He has served on international and national committees throughout his career in interventional pulmonology and lung cancer. He is currently the Director of Interventional Pulmonology and Lung Cancer Screening at Henry Ford Hospital. He also works as an Associate Medical Officer for Intuitive, working on new technology development and design of research surrounding this work.
When not at work, he looks forward to spending time with his wife of 34 years. He also enjoys traveling, photography, hiking, golfing, cycling, woodworking, gardening, and he is a beekeeper.
Asst Prof. Sinha is a physician-scientist trained in the U.K. and practicing in the U.S. His research interests include lung biology and immune responses, respiratory physiology, and data science. As a clinician, he specialises in Intensive Care and Emergency Medicine. His group are studying molecular biology in critical care syndromes such as sepsis and ARDS. He uses multidimensional biological and clinical data to find biologically homogeneous subgroups in ARDS and sepsis with a view to developing precision-based care in the ICU. As a data scientist he uses cutting-edge tools to understand biological data at a population-wide level and to seek subgroups in clinical trials that may be treatment responsive or how we can better design trials that can evaluate treatment efficacy at an individual level. Through these novel tools he hopes to improve patient outcomes by matching the right therapies to the right patient at the right time.
Dr. Yuanlin Song is the Director of Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University; He is also the Standing committee member, Chinese Thoracic Society; Standing committee member, APSR; President, Shanghai respiratory society; Past Assembly Head, Respiratory Infectious Disease, Asia Pacific Society of Respirology and Associate Editor, Respirology.
He has authorized more than 200 publications in JAMA-internal Medicine, Lancet, JCI, Critical Care Med, Am J Respir Crit Care Med, Stem Cell, etc, with H-index 59. He also got 20 approved patents and coauthored 12 book chapters.
Asso. Prof Sng Li-Hwei Is a Senior Consultant at the Central Tuberculosis Laboratory, Department of Medicine, Singapore General Hospital. She served the Head of CTBL and has been in various biosafety and TB guidelines committees of the Ministry of Health, Singapore, and the Singapore Tuberculosis Elimination Program. Her interests are in laboratory diagnosis of mycobacteria, in particular, the identification and epidemiology of multidrug resistant organisms.
Dr Arietta Spinou is a cardiorespiratory physiotherapy lecturer and researcher at King’s College London, United Kingdom. Dr Spinou holds a PhD in Respiratory Medicine, King’s College London, and an MSc in Cardiorespiratory Physiotherapy, UCL. She also has over 13 years of clinical experience in Greece, Finland and the UK.
Dr Spinou is a member of the British Thoracic Society (BTS) Pulmonary Infection Specialist Advisory Group and was a chair of the European Respiratory Society (ERS) airway clearance in bronchiectasis statement panel (2023). Her research interests include bronchiectasis, quality of life, cough physiology and outcomes, and airway clearance techniques.
Alastair is Chair of Pharmacology and Therapeutics at University of Melbourne and Director of the ARC Industrial Transformation Centre for Personalised Therapeutic Technologies. He focusses on drug targeting in remodelling and inflammation. He is CSO and Director of TianLi Biotech and President of the Asia Pacific Federation of Pharmacologists.
Sun Tao is the Advanced Practice Nurse in Home Ventilation and Respiratory Support Service (HVRSS) of Tan Tock Seng Hospital. Trained in China, she started as an enrolled nurse in a multi-disciplinary ICU in Singapore. 10years of ICU experience enabled her to became the first nurse in HVRSS in 2012. Over the years, she led HVRSS nurses to venture and expand in the scope of service, such as tracheostomy tube change by 2 nurses without a doctor in patient’s home. Her interest is in education and training in the community. She is committed to improve the knowledge and skills of professional and non-professional caregivers in long term ventilation.
Asst Prof. Angela Takano is a Senior Consultant with the Department of Anatomical Pathology at Singapore General Hospital.
She completed her pathology training in the United States of America at Beth Israel-Deaconess Hospital, followed fellowships in Surgical Pathology and Cytopathology Fellowship at Harford Hospital in Connecticut, and Oncologic Pathology Fellowship at Memorial Sloan-Kettering Cancer Center in New York City.
She dedicates to clinical work in general pathology, pulmonary pathology and cytopathology, as well as teaching medical students and residents and collaborating in lung cancer research with the Lung Cancer Consortium of Singapore.
Dr Tam is Senior Consultant and founding Head of Thoracic Surgery at the National University Heart Centre, Singapore. He is also an Associate Professor of Surgery at the National University of Singapore Yong Loo Lin School of Medicine. He obtained the Bachelor of Science in Biochemistry with First Class Honours (BSc Hon) and Doctor of Medicine (M.D.) degree at the University of Alberta, Canada, and underwent Thoracic Surgery residency training at the University of Manitoba in Canada. He also earned the Master of Education and Master of Science degrees from the University of Manitoba in Canada. He is a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCSC). He was a Clinical Instructor at the Advance Minimally Invasive Thoracic Surgery Centre at the University of Pittsburgh in USA.
Dr Tam specialises in performing advanced minimally invasive surgery using single-port techniques with Uniportal Video-Assisted Thoracoscopic Surgery (UVATS). He was an early pioneer in UVATS lobectomy, performing the first UVATS lobectomy in 2009. He is a champion of enhanced recovery protocols and opioid free analgesia to maximise patients’ comfort, well-being and quality of life after surgery. He leads a high-performance team of thoracic surgeons with excellent surgical outcomes and is passionate with educating the next generations of thoracic surgeons in Singapore and Asia.
Dr Tam specializes in translational clinical research encompassing two domains. The first is applied surgical science in the clinical domain, which includes minimally invasive techniques, enhanced recovery protocols, opioid free analgesia, pain reduction techniques, surgical devices and pneumo-static sealants. The second domain is translation of basic scientific research to clinical applications, which includes mapping of specialise cells in the lung, extracellular vesicles, exosomes, miRNA, and liquid biopsies for early lung cancer detection. He has many research publications in top high-impact international-refereed journals, including Science, Nature, Cell, Immunity, New England Journal of Medicine, Annals of Thoracic Surgery and other top journals in the field of Thoracic Surgery.
Dr Tam is a passionate educator, accomplished faculty developer, and esteemed academic leader. He is currently the Chairman of the Cardio-Thoracic Surgery Residency Advisory Committee at the Ministry of Health, Singapore. He is the Chair of the Multi-disciplinary Lung and Thoracic Cancer Programme at the National Cancer Institute, Singapore. He holds numerous leadership roles and administrative appointments, and has won multiple awards in clinical excellence, research, and education.
Clin A/P (Dr) Tan has been a Family Physician cum senior consultant for the past 15 years. He is a Fellow with the College of Family Physicians Singapore and Academy of Medicine who graduated as one of the six pioneer group of clinicians in the Master in Clinical Investigations in NUS. Since his appointment as Director of Research in SHP in 2012, A/P Tan has been coaching medical and nursing undergraduates, Family Medicine Residents and Family Physicians in Family Medicine Research. His research interests focus on improving person-centred care via technology and innovation. A/P Tan is also the recipient of the Humanity Award in 2006 for research relating to SARS, SingHealth Excellence Award for Clinician in 2012. He is the first family physician to receive the NMRC Clinician Innovator Development Award in 2019 to develop a novel internet of thing system to promote smoking cessation. Recent awards received are NMRC Clinician Innovators Development Award (CIDA) in 2020, Singapore Public Administration Bronze Medal (Pingat Pentadbiran Awam Gansa) in 2021, Singapore Health Quality Service Superstar Merit Award in 2022 and Duke NUS Master Academic Clinician award in 2022. He has published more than 120 papers in peer-reviewed journals and received awards for oral and poster presentations at various WONCA and Family Medicine Conferences.
Dr Tan Geak Poh is a consultant respiratory physician who is currently practicing at the Department of Respiratory & Critical Care Medicine, Tan Tock Seng Hospital. Dr Tan’s main interest is in the field of clinical pulmonary physiology and sleep medicine. Dr Tan completed a fellowship in advanced pulmonary function testing, sleep and non-invasive ventilation at the Department of Pulmonary Physiology and Sleep Medicine, Sir Charles Gairdner Hospital, Australia. He leads the TTSH Respiratory Function Laboratory since 2017 and initiated new services including impulse oscillometry and cardiopulmonary exercise testing. He is actively involved in laboratory quality improvement projects and multi-center research in the validation of spirometry reference equations. He is a Fellow at the Academy of Medicine Singapore and Royal College of Physicians Edinburgh.
Dr Tan Shera is a respiratory physician and intensivist with special interest in Tuberculosis and Nontuberculous Mycobacteria. She is currently the clinical director of the TB Control Unit. Dr Shera received her training at National Jewish Health in Denver, USA. She is heavily involved in the clinical care of TB patients, including those with Multi-drug Resistant TB, as well patients with complex non tuberculous mycobacteria diseases due to underlying immunodeficiency.
Dr. Tan Yi Hern completed his medical education in Singapore and graduated from National University of Singapore, Yong Loo Lin School of Medicine in 2011. He completed Singhealth Respiratory Medicine Senior Residency in 2019 and Advanced Specialist Training in Intensive Care Medicine in 2020. He is part of the Interstitial Lung Disease team at Singapore General Hospital and his other interests include pulmonary infections in immunocompromised hosts as well as intensive care.
Augustine Tee is Deputy Chairman Medical Board (Medical Disciplines) and Senior Consultant Respiratory Physician & Intensivist at Changi General Hospital, Singapore. He is an Adjunct Associate Professor with SingHealth Duke-NUS, Lee Kong Chian School of Medicine, and Yong Loo Lin School of Medicine in Singapore. Dr Tee has been engaged in leading roles at various Respiratory professional bodies such as the Chapter of Respiratory Physicians, Singapore Thoracic Society, Asthma & Allergy Association, Society of Intensive Care Medicine, and Residency Advisory Committees at both Respiratory Medicine and Internal Medicine, where he is also an examiner for the specialist exit exams. He is the ex-Co-chair of the Ministry of Health (MOH) COPD Service Improvement Team and member of the MOH Agency for Care Effectiveness expert group on the Appropriate Care Guides for COPD diagnosis.
Conjoint Associate Professor ARTHUR TENG is a senior staff specialist paediatrician, sleep physician and Head of the Department of Sleep Medicine at the Sydney Children’s Hospital, Randwick. Currently he is Conjoint Associate Professor of Medicine at the University of New South Wales (UNSW) and Clinical Senior Lecturer at the University of Tasmania. He was Respiratory Fellow and Chief Resident at the then Prince of Wales Children’s Hospital before training with Professor Colin Sullivan at the David Read Laboratories, University of Sydney, about ten years following the invention of CPAP. His clinical and research interests include the neuropsychological impact of sleep disorders in children, parasomnias, infantile obstructive sleep apnoea and childhood narcolepsy. He has published across the broad spectrum of paediatric sleep disorders in peer-reviewed journals including Sleep, J Applied Physiology, AJRCCM, ERJ, Sleep Medicine, J of Sleep Research, Respirology etc, and several text book chapters. He has supervised and is currently supervising Honours, Masters and PhD Projects through the Universities of Sydney and NSW. He has trained over 20 scientists, paediatric sleep, and respiratory physicians, from Australia and around the world including New Zealand, Hong Kong, China, Malaysia, Singapore, UK, India, Canada, Taiwan and Brazil.
Prof Bruce Thompson AM
B.App.Sci, CRFS, FANZSRS, FAPSR, FThorSoc, Phd
Head of Melbourne School of Health Sciences, University of Melbourne
Professor Bruce Thompson is an active clinical scientist, with over 30 years of experience working in hospitals, universities, the community sector and business. He is a key opinion leader in respiratory medicine nationally and internationally and sits on numerous national and international scientific and clinical committees, and boards for the profession, non-government and not for profit organisations, and industry.
He is a past president of the Thoracic Society of Australia and New Zealand. Prof Thompson developed an international reputation in pulmonary gas exchange physiology early in his career whilst doing his PhD in conjunction with the NASA physiology laboratory at the University of California San Diego. For the first 27 years of is career, he worked in clinical respiratory and sleep laboratories in major teaching hospitals. Throughout this time, he has developed and focused his research on the physiology of small airway function. The work is being approached on a number of fronts including physiology measurement, imaging, and mathematical modelling. Since that time Prof Thompson is now regarded as an international expert on clinical respiratory measurement. His published works include a book on lung function, as well as numerous book chapters and 165 peer-reviewed journal articles and official documents. As an established clinical researcher in lung function, asthma, allergies and respiratory health, Bruce has been awarded competitive grants of over $35.9M including NHMRC and ARC schemes. He is a past President of the Thoracic Society of Australia and New Zealand and was the first non-medical president in the history of the society, and is a Fellow of Australian and New Zealand Society of Respiratory Science, Thoracic Society of Australia and New Zealand and finally Asia Pacific Society of Respirology. He has extensive international reputation across medicine (respiratory and cardiovascular) and biomedical engineering. His international reputation has led to him being invited to participate on five American Thoracic Society/European Respiratory Society task forces and is currently a co-chair of the ATS/ERS task force writing the Lung Function interpretation document which is to be used across all lung function laboratories globally. Prof Thompson’s strengths is bringing non-traditional expertise to clinical healthcare and biomedicine, using his varied contacts and expertise to build truly cross-disciplinary projects.
Marko Topalović, PhD is a CEO of ArtiQ (Leuven, Belgium), an artificial intelligence (AI)-based software company that aims to become the trusted partner of medical practitioners for diagnosis, treatment, and follow-up of respiratory problems.
Prior to co-founding the ArtiQ (University spin-off), as a postdoctoral researcher in the University Hospital in Leuven, Marko worked on improving and developing machine learning algorithms for diagnosing lung diseases. Marko obtained a PhD degree on the topic “Artificial intelligence for pulmonary function tests” in the Laboratory for respiratory disease, at the prestigious KU Leuven (Belgium). With an MSc in Computer Sciences, he continually tries to connect two fields with a goal to augment healthcare using state-of-the-art technology. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Moreover, he received international awards on several different occasions. Marko earned his business education from the Flanders Business School (Belgium).
Associate Professor Lauren Troy is a senior staff specialist in Respiratory Medicine at Royal Prince Alfred, Camperdown, Sydney, affiliated with the Central Clinical School, Sydney Medicine, University of Sydney, and Co-Director of the RPA Institute for Academic Medicine. She has clinical and research interests in interstitial lung disease, interventional pulmonology, and lung cancer. She was the principal investigator of the “COLDICE Study”, informing international guidelines on the role of transbronchial lung cryobiopsy in ILD diagnosis, and is an investigator on the Australian NHMRC Centre for Research Excellence in “Interstitial Lung Disease – towards individualised care” program.
Dr. Hao-Chien Wang is professor of Internal medicine in College of Medicine National Taiwan University and consultant physician in Chest specialty practicing at National Taiwan University Hospital in Taipei city. Now he is the chairman of Taiwan Society of Pulmonary & Critical Medicine since 2020. He also is the deputy head of COPD assembly of APSR.
Dr. Wang has an outstanding career marked by contributions to academic research, education, training and clinical practice. Dr. Wang’s research focuses mainly on basic and clinical researches on obstructive airway diseases, acute lung injury and chest ultrasonography in diagnosing of pulmonary diseases,. He has published more than 100 papers in national and international peer reviewed journals. Furthermore, Dr. Wang is an investigator for several ongoing global clinical studies in the area of respiratory disease including pneumonia, COPD & asthma.
Peter Wark is the Director of Cystic Fibrosis and RES2, AIRMED, Alfred Health, Melbourne. He is a conjoint Professor of Medicine at Monash University. He holds an honorary position as a senior staff specialist in Respiratory and Sleep Medicine at John Hunter Hospital, Newcastle and is an adjunct Professor with the University of Newcastle and senior affiliate researcher at the Hunter Medical Research Institute (HMRI) Immune Health Research programme at HMRI.
His research interests are; airway inflammation in the context of chronic airways disease, innate immunity, the role of infection in chronic airways disease and translational clinical trial design. His group has developed expertise in identifying respiratory viruses in airway secretions and developing an in-vitro cell culture model of the airway epithelium that we use to model the effect of infection and inflammation. His research focuses upon factors that increase susceptibility to virus infection in asthma, COPD, Cystic Fibrosis and bronchiectasis. Characterising airway inflammation and innate immune responses in chronic airways disease and applying this to clinical care, as well as the development of precise individualised management strategies.
He is currently on the board of directors for Cystic Fibrosis Australia and the National Asthma Council.
Wisia Wedzicha is Professor of Respiratory Medicine, Head of the Respiratory Division at the National Heart and Lung Institute, Imperial College and Honorary Consultant at Royal Brompton and Harefield Hospitals. She qualified from Somerville College, Oxford University and St Bartholomew’s Hospital Medical College. She was elected as Fellow of the Academy of Medical Sciences (FMedSci) and is a fellow both of the American Thoracic Society (ATSF) and European Respiratory Society (FERS). She received the Helmholtz International Fellow Award in 2014.
Professor Wedzicha has a major interest in the causes, mechanisms, impact and prevention of chronic obstructive pulmonary disease (COPD) exacerbations, and in the role of bacterial and viral infection in COPD exacerbations. She directs an active research group specialising in COPD exacerbations, and has published extensively on this topic.
Professor Wedzicha was Editor-in-Chief of Thorax from 2002 to 2010 and is currently Editor in Chief for the American Journal of Respiratory and Critical Care Medicine. She was the Lancet Ombudsman till 2014, Publications Director for the European Respiratory Society (ERS) and has also previously been ERS Guidelines Director.
Athol Wells, MD, is a Professor of Respiratory Medicine at the Royal Brompton Hospital and Imperial College, London. He trained in New Zealand, moving to the Royal Brompton Hospital in 1999, heading the ILD Unit from 2007 to 2016 and continuing to chair the ILD research group. His research interests include the applicability of CT in ILD diagnosis and prognostic evaluation, patterns of progression in individual ILDs. He created and developed the ILD disease behaviour classification. He received the ERS lifetime achievement in ILD in 2019 and the ERS Presidential Award in 2023. He is a member of the Fleischner Society and current president of the World Association of Sarcoidosis and other Granulomatous Diseases (WASOG). He is one of the most cited world researchers in ILD. In September 2023, his h-index in the Google Scholar Citations database was 151 (101 since 2018), with over 90,000 citations in total.
Sophie West is a respiratory consultant in Newcastle upon Tyne and lead of the Regional Sleep Service. Her clinical and research interests are in best treatments for Obstructive Sleep Apnoea and its associated conditions. She was a committee member for the NICE NG202 Obstructive Sleep Apnoea-Hypopnoea Syndrome and Obesity Hypoventilation Syndrome Guideline, and now sits on the NICE Diagnostics Advisory Committee reviewing Automated home testing devices for diagnosing obstructive sleep apnoea/hypopnoea syndrome.
She authored the Oxford Handbook of Respiratory Medicine for the first three editions.
She is a member of the British Thoracic Society Executive Council and Workforce Committee since 2021.
She is Chair of the Cardiothoracic Board, Newcastle upon Tyne Hospitals
Professor W.S. Fred Wong received his PhD in Pharmacology from the Ohio State University in Columbus, Ohio. He did his postdoctoral training in the Lilly Research Laboratories at Indianapolis and in the Respiratory and Critical Care Medicine Division at the Brigham and Women’s Hospital in Boston. Professor Wong joined the Department of Pharmacology at The National University of Singapore (NUS) in 1995 and since built the Respiratory Pharmacology Laboratory. His research interest is to identify therapeutic targets and to discover and develop novel drug molecules for the treatment of chronic airway inflammation including asthma, COPD and pulmonary fibrosis. Professor Wong was ranked top 2% of scientists worldwide in 2022.
Pan-Chyr Yang, MD, PhD National Taiwan University College of Medicine and National Taiwan University Hospital, Institute of Biomedical Sciences, Genomics Research Center, Academia Sinica, Taiwan.
Dr. Yang is Chair Professor of National Taiwan University. He is former president of National Taiwan University and member of Academia Sinica, World Academic of Science and the National Academy of Inventors. His research interests are lung cancer genomics and precision cancer therapy. He is actively involved in developing novel strategies, including multi-omics, aptamer, nanotechnology and siRNA to improve diagnosis and therapy for cancer and infectious diseases, including COVID-19. His team recently by proteogenomics revealed distinct genetic and environmental signatures of lung cancer pathogenesis and progression in never-smokers. He received the 2020 IASLC Joseph W. Cullen Distinguished Award because of the contributions in leading the lung cancer screening and improving the survival of lung cancer patients.
Dr. Kim Hoong Yap is a senior consultant respiratory physician. He completed his advanced specialist training in Respiratory Medicine in 2012 in Singapore. This was followed by sub-specialty fellowship training in pleural disorders, thoracoscopy and endobronchial ultrasonography in Sir Charles Gairdner Hospital, Perth, Australia in 2014. He was also a fellow in interventional pulmonology in Siriraj Hospital, Bangkok, Thailand in 2016. He currently leads the Pleural Service in Tan Tock Seng Hospital, Singapore. He holds a position of Clinical Senior Lecturer in Yong Loo Lin, School of Medicine, National University Singapore and Faculty Member of the National Healthcare Group (NHG) Respiratory Medicine Residency Program. His interests include pleural infections, thoracoscopy and lung cancer diagnostics.
Respiratory physician and working as the professor of Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, located in the northeast of Kyushu island in Japan.
Specialized clinical fields are general respiratory medicine, occupational lung disease including pneumoconiosis and occupational asthma, obstructive lung disease (asthma and COPD), interstitial lung diseases and respiratory infections.
Research interests focus on the occupational and environmental pollution exposure on respiratory health and diseases, and also bacterial, mycobacterial and viral respiratory pathogens in acute and chronic lower respiratory tract infections such as bacterial/viral pneumonia, nontuberculous mycobacteriosis and bronchiectasis.
It is my great pleasure to work as the Chairperson of the Central Congress Committee and Head-elect of the Environmental & Occupational Health and epidemiology (EOHE) assembly in APSR.
Professor Brendon Yee is a senior staff specialist in Respiratory and Sleep Medicine at Royal Prince Alfred Hospital, Camperdown, Sydney, affiliated with Central Clinical School, Sydney Medicine, University of Sydney. He is the Head, Discipline of Sleep Medicine, Sydney University. He is a Senior Researcher in the Sleep Research Group at the Woolcock Institute of Medical Research. He has a broad clinical and research intertest in both respiratory and non-respiratory sleep disorders and respiratory failure.
He is a current (and previous) investigator in a number of NHMRC grants, NHMRC Centre of Excellence and MRFF grants. He has published extensively (over 140 publications) in peer reviewed journals and textbooks.
He has trained and mentored many adult sleep medicine fellows/physicians from Australasia, Asia and Europe.
He was the previous Chair of the Professional Standards Committee at the Thoracic Society of Australia and New Zealand (TSANZ). He currently serves on the clinical committee in the Australasian Sleep Association (ASA). He is part of the International Sleep Research Training Program for the World Sleep Society.
Dr Chan Yeow graduated from National University of Singapore , Faculty of Medicine ( now known as Yong Lu Lin School of Medicine) in 1994 . He completed Anaesthesiology training in 2003. He underwent a fellowship in Intensive Care Medicine in Melbourne, Victoria in 2004 ( at both the Austin and Repatriation Medical Centre, and The Alfred). He obtained the European Diploma of Intensive Care in 2006.
In 2009, he was appointed the Director of the Home Ventilator Service, which was renamed the Home Ventilation and Respiratory Support Service subsequently. This service currently receives mainstream MOH funding, and is the only de facto adult complex home ventilation service in Singapore.
The HVRSS team underwent a team fellowship in Paris ( L’Hopital Pitie-Salpetriere) and Paris ( the Royal Brompton Hospital) in 2010. The team has hosted numerous visiting experts, and has conducted courses in chronic ventilation locally and in the region.
The HVRSS team currently looks after more than a hundred and eighty complex ventilation users, and has cumulatively looked after more than four hundred ventilation users. In 2022, the team was awarded the Service Delivery Excellence Award of the Public Sector Transformation Awards 2022.
Dr Chan Yeow is interested in philosophy, history and traditional martial arts. He practices Goju Ryu Karate and Taizuquan. He also plays the Erhu.
Dr. Yoshida is a graduate from Mie University School of Medicine (MD) in Japan. His graduate research training (PhD) was completed in Osaka where he demonstrated lung injury resulting from strong spontaneous effort during mechanical ventilation. He furthered this during a year’s work with Dr. Amato (University of São Paulo) where he described ‘Pendelluft’, a new mechanism of effort-dependent lung injury, and developed extensive knowledge of pleural pressure mechanics. He has completed an additional 3-year post-doctoral fellowship in Toronto (Drs. Kavanagh and Brochard) exploring translational research on pleural pressure and its manipulation. Dr. Yoshida has won multiple hospital, university and international awards, most recently the ‘Global Rising Star’ award from the Australian and New Zealand Intensive Care Society. He has taken up a faculty position in Osaka University Graduate School of Medicine (July 2018). Ultimately, Dr. Yoshida pursues translational research towards helping critically ill patients with acute lung disease
Assoc Prof. Barnaby Edward Young is a Senior Consultant at the National Centre for Infectious Diseases in Singapore. He holds a Ph.D. from Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, where he investigated influenza vaccination strategies in the tropics.
At NCID he has contributed significantly to the understanding of COVID-19 through epidemiological and clinical characterization studies. He has published extensively on COVID-19, including studies on viral dynamics, immune responses, and treatment outcomes. With Dr Darius Beh he runs the Long COVID clinic at NCID which was established in November 2021. A/Prof. Young has also been involved in research related to influenza and pneumonia in tropical regions, aiming to improve year-round protection against influenza in older adults. His work includes clinical trials, systematic reviews, and investigations into vaccine effectiveness and immune responses.
In recognition of his research contributions, A/Prof. Young has received the National Medical Research Council Clinician Scientist Award, and the Public Administration Medal (Bronze) for his work during the COVID-19 pandemic.